Description     Claims     Drawing  

US61700252   [0001]  [0029] 
US61708466B   [0001] 
US61764421B   [0001] 
US61542469   [0029] 
US61700234   [0029] 
US61708413   [0029] 
US61708466   [0029] 
US61708503   [0029] 
US61806717   [0029] 
US31471211   [0029] 
US2012000442W   [0029] 

Science   [0003]  [0005] 
Nature   [0003]  [0004] 
Science   [0003]  [0005] 
Immunity   [0003]  [0003]  [0003]  [0005] 
Science   [0003]  [0003]  [0005]  [0023]  [0030]  [0030]  [0034]  [0042]  [0050]  [0050]  [0051]  [0051]  [0053] 
Science   [0003]  [0003]  [0005]  [0005]  [0006]  [0030]  [0030]  [0030]  [0034]  [0052]  [0053] 
Science   [0003]  [0003]  [0003]  [0003]  [0005]  [0030]  [0030]  [0034]  [0043]  [0043]  [0045]  [0053]  [0054]  [0058] 
F1000 Biol. Rep.   [0003] 
Curr. Opin. Immunol.   [0003] 
Science   [0003]  [0049]  [0057]  [0057] 
Nat. Biotechnol.   [0003]  [0005]  [0006]  [0021]  [0022]  [0033]  [0052] 
Cell Mol. Life Sci.   [0003] 
Nature   [0003]  [0006]  [0050] 
AIDS Res. Human Retrovirol.   [0003]  [0006] 
MAbs   [0003]  [0005]  [0006] 
PLoS Pathog.   [0003]  [0003]  [0006]  [0033]  [0039]  [0052] 
J. Virol.   [0003] 
Biochem. Biophys. Res. Commun.   [0003]  [0003]  [0006]  [0054] 
J. Virol.   [0003]  [0006]  [0030]  [0041] 
J. Virol.   [0003]  [0004]  [0005] 
Nature   [0003]  [0006]  [0020]  [0057] 
Science   [0003]  [0030]  [0034]  [0053]  [0054] 
PLoS Pathog.   [0003]  [0003] 
Proc. Natl. Acad. Sci. USA   [0004]  [0039]  [0061] 
Proc. Natl. Acad. Sci. USA   [0004]  [0004] 
PLoS One   [0004]  [0004]  [0005] 
PLos One   [0004] 
J. Virol.   [0004] 
J. Exp. Med.   [0004]  [0005] 
J. Virol.   [0004]  [0050]  [0051] 
Curr. Opin. HIV AIDS   [0004]  [0005] 
J. Virol.   [0004] 
J. Virol.   [0004] 
J. Exp. Med.   [0005]  [0030]  [0030]  [0030]  [0030]  [0033]  [0040]  [0052]  [0052] 
BMC Bioinformatics   [0015] 
Syst. Biol.   [0015] 
Comput Applic Biosci   [0015] 
Bioinformatics   [0015] 
R Core Team. 2012. R: A language and environment for statistical computing. R Foundation for Statistical Computing   [0015] 
Korber J Virol.   [0015] 
Proc. Natl. Acad. Sci. USA   [0019] 
J. Immunol.   [0020]  [0030]  [0041] 
J. Virol.   [0020] 
Science   [0021] 
Virology   [0023] 
J. Virol.   [0023] 
Nature Med.   [0026] 
Clinical Vaccine Immunol.   [0026] 
CLINICAL VACCINE IMMUNOL.   [0026] 
Nature Med.   [0026] 
J Virol.   [0028] 
Vaccine   [0028] 
Science   [0028] 
Science   [0028] 
J. Immunol. Methods   [0030]  [0034]  [0050] 
Sci. Transl. Med.   [0030]  [0052] 
J. Virol.   [0030]  [0041] 
J. Virol.   [0030]  [0042]  [0051] 
Cur. Protoc. Immunol.   [0030] 
Biostatistical Analysis   [0033] 
Bioinformatics   [0034] 
The Journal of Infectious Diseases   [0035] 
J. Virol. Methods   [0038] 
Immunity   [0038]  [0039]  [0040] 
J. Meth. Virol.   [0038] 
Journal of Virology   [0039] 
Virology   [0039] 
The Journal of Infectious Diseases   [0042]  [0042] 
Methods in Enzymology   [0045] 
J. Appl. Crystallogr.   [0046] 
Crystallographica Section D   [0046] 
Acta Crystallogr. D. Biol. Crystallogr.   [0047] 
Acta Crystallogr. D. Biol. Crystallogr.   [0047]  [0048] 
Nucleic Acids Res.   [0047] 
BMC Bioinformatics   [0047] 
C. Sequences of Proteins of Immunological Interest   [0047] 
J. Mol. Biol.   [0048] 
J. Virol.   [0050] 
J. Virol.   [0053] 
Hum. Antibodies   [0057] 
Science   [0057] 
Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops   [0067] 
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1)   [0067] 
Not so different after all: a comparison of methods for detecting amino acid sites under selection   [0074] 
Detecting individual sites subject to episodic diversifying selection   [0074] 
Proc. Natl. Acad. Sci.   [0075] 
Clin Vaccine Immunol.   [0075] 
Nature   [0075] 
NEJM   [0075] 
PLoS One   [0075] 
J. Virol.   [0075] 
J. Virol.   [0084] 
Nature   [0085] 
Nature Rev. Immunol.   [0085] 
New Eng. J. Med.   [0085] 
PLoS Pathog.   [0085] 
J. Exp. Med.   [0085] 
Proc. Natl. Acad. Sci.   [0085] 
J. Virol.   [0085] 
PLoS Pathogens   [0085] 
J. Virol.   [0085] 
PLoS One   [0085] 
Immunity   [0085] 
Nature Biotech.   [0085]